Cargando…
Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance
Previously reported in vitro release test methods for drug-releasing vaginal rings containing poorly water-soluble drugs have described use of water-alcohol systems or surfactant solutions in efforts to maintain sink conditions. Here, as part of efforts to more closely match in vitro and in vivo rel...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315348/ https://www.ncbi.nlm.nih.gov/pubmed/34674162 http://dx.doi.org/10.1007/s13346-021-01081-7 |
_version_ | 1785067490624143360 |
---|---|
author | Murphy, Diarmaid J. Lim, Deanna Armstrong, Ryan McCoy, Clare F. Bashi, Yahya H. Dallal Boyd, Peter Derrick, Tiffany Spence, Patrick Devlin, Bríd Malcolm, R. Karl |
author_facet | Murphy, Diarmaid J. Lim, Deanna Armstrong, Ryan McCoy, Clare F. Bashi, Yahya H. Dallal Boyd, Peter Derrick, Tiffany Spence, Patrick Devlin, Bríd Malcolm, R. Karl |
author_sort | Murphy, Diarmaid J. |
collection | PubMed |
description | Previously reported in vitro release test methods for drug-releasing vaginal rings containing poorly water-soluble drugs have described use of water-alcohol systems or surfactant solutions in efforts to maintain sink conditions. Here, as part of efforts to more closely match in vitro and in vivo release for the 25 mg dapivirine matrix-type silicone elastomer vaginal ring for HIV prevention, we have investigated alternatives to the 1:1 v/v water/isopropanol medium described previously. Specifically, we evaluated dapivirine release from rings into (i) monophasic water/isopropanol mixtures of varying compositions and (ii) biphasic buffer/octanol systems using pH 4.2 and pH 7.0 buffers. The rate and mechanism of dapivirine release were dependent upon the isopropanol concentration in the release medium, in accordance with the observed trend in drug solubility. At 0 and 10% v/v isopropanol concentrations, dapivirine release followed a partition-controlled mechansim. For media containing ≥ 20% v/v isopropanol, in vitro release of dapivirine was significantly increased and obeyed permeation-controlled kinetics. Cumulative release of ~3.5 mg dapivirine over 28 days was obtained using a water isopropanol mixture containing 20% v/v isopropanol, similar to the ~4 mg dapivirine released in vivo. Dapivirine release into the biphasic buffer/octanol system (intended to mimic the fluid/tissue environment in vivo) was constrained by the limited solubility of dapivirine in the buffer component in which the ring resided, such that cumulative dapivirine release was consistently lower than that observed with the 20% v/v isopropanol in water medium. Release into the biphasic system was also pH dependent, in line with dapivirine’s pK(a) and with potential implications for in vivo release and absorption in women with elevated vaginal pH. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13346-021-01081-7. |
format | Online Article Text |
id | pubmed-10315348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-103153482023-07-04 Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance Murphy, Diarmaid J. Lim, Deanna Armstrong, Ryan McCoy, Clare F. Bashi, Yahya H. Dallal Boyd, Peter Derrick, Tiffany Spence, Patrick Devlin, Bríd Malcolm, R. Karl Drug Deliv Transl Res Original Article Previously reported in vitro release test methods for drug-releasing vaginal rings containing poorly water-soluble drugs have described use of water-alcohol systems or surfactant solutions in efforts to maintain sink conditions. Here, as part of efforts to more closely match in vitro and in vivo release for the 25 mg dapivirine matrix-type silicone elastomer vaginal ring for HIV prevention, we have investigated alternatives to the 1:1 v/v water/isopropanol medium described previously. Specifically, we evaluated dapivirine release from rings into (i) monophasic water/isopropanol mixtures of varying compositions and (ii) biphasic buffer/octanol systems using pH 4.2 and pH 7.0 buffers. The rate and mechanism of dapivirine release were dependent upon the isopropanol concentration in the release medium, in accordance with the observed trend in drug solubility. At 0 and 10% v/v isopropanol concentrations, dapivirine release followed a partition-controlled mechansim. For media containing ≥ 20% v/v isopropanol, in vitro release of dapivirine was significantly increased and obeyed permeation-controlled kinetics. Cumulative release of ~3.5 mg dapivirine over 28 days was obtained using a water isopropanol mixture containing 20% v/v isopropanol, similar to the ~4 mg dapivirine released in vivo. Dapivirine release into the biphasic buffer/octanol system (intended to mimic the fluid/tissue environment in vivo) was constrained by the limited solubility of dapivirine in the buffer component in which the ring resided, such that cumulative dapivirine release was consistently lower than that observed with the 20% v/v isopropanol in water medium. Release into the biphasic system was also pH dependent, in line with dapivirine’s pK(a) and with potential implications for in vivo release and absorption in women with elevated vaginal pH. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13346-021-01081-7. Springer US 2021-10-21 2023 /pmc/articles/PMC10315348/ /pubmed/34674162 http://dx.doi.org/10.1007/s13346-021-01081-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Murphy, Diarmaid J. Lim, Deanna Armstrong, Ryan McCoy, Clare F. Bashi, Yahya H. Dallal Boyd, Peter Derrick, Tiffany Spence, Patrick Devlin, Bríd Malcolm, R. Karl Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
title | Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
title_full | Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
title_fullStr | Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
title_full_unstemmed | Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
title_short | Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
title_sort | refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315348/ https://www.ncbi.nlm.nih.gov/pubmed/34674162 http://dx.doi.org/10.1007/s13346-021-01081-7 |
work_keys_str_mv | AT murphydiarmaidj refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT limdeanna refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT armstrongryan refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT mccoyclaref refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT bashiyahyahdallal refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT boydpeter refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT derricktiffany refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT spencepatrick refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT devlinbrid refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance AT malcolmrkarl refiningtheinvitroreleasetestmethodforadapivirinereleasingvaginalringtomatchinvivoperformance |